Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 2091204 | 5-hydroxy-2,4-dimethylpyrimidine | 412003-95-3 | ≧96.0% | _412003-95-3.png) |
| 2,4-dimethylpyrimidin-5-ol is a key intermidiate ofLemborexant. Kg scale may be provi | ||||
| 20548 | Pimicotinib ( ABSK02 ) | 2253123-16-7 | ≧98.0% | _2253123-16-7.png) |
| Pimicotinib is a novel small molecule inhibitor of CSF-1R, which is orally available, | ||||
| 24003 | NVL-655 ( ALK-IN-27 ) | 2739866-40-9 | ≧98.0% | .png) |
| NVL-655 is a novel, brain-penetrant, ALK-selective inhibitor that was designed to add | ||||
| 20656 | IK-930 | 2563892-44-2 | ≧98.0% |  |
| IK-930 is a novel, selective, small molecule inhibitor of TEAD that prevents palmitat | ||||
| 41788 | CB-6644 | 2316817-88-4 | 96.33% |  |
| CB-6644 acts as a noncompetitive ATPase inhibitor. Additionally, it can inhibit RUVBL | ||||
| 21075 | 1-cyanocyclohexyl 4-methylbenzenesulfonate | 90775-01-2 | ≧98.0% |  |
| 1-cyanocyclohexyl 4-methylbenzenesulfonate (CAS 90775-01-2 ) is an important building | ||||
| 61726 | Ensifentrine ( RPL554 ) | 1884461-72-6 | ≧98.0% | _1884461-72-6.png) |
| Ensifentrine (RPL554) is an investigational, first-in-class, inhaled dual inhibitor o | ||||
| 21238 | Seralutinib | 1619931-27-9 | 98% Min. |  |
| Seralutinib, also known as PK-10571 and GB002, is a Novel Inhaled Pdgfr Kinase Inhibi | ||||
| 171653 | 4-Bromo-6-methylpyridine-2-carbonitrile | 886372-53-8 | ≧95.0% |  |
| 4-Bromo-6-methylpyridine-2-carbonitrile, CAS 886372-53-8 | ||||
| 21253 | indole-4-boronic acid pinacol ester | 388116-27-6 | ≧95.0% |  |
| indole-4-boronic acid pinacol ester, CAS 388116-27-6, is an important intermeidate. | ||||
| 20513 | ZINC40099027 (ZN27) | 1211825-25-0 | ≧98.0% |  |
| ZINC40099027 (ZN27) is a specific focal adhesion kinase (FAK) activator that promotes | ||||
| 24001 | Bomedemstat | 1990504-34-1 | ≧98.0% |  |
| Bomedemstat is anorally available, irreversible inhibitor of lysine-specific demethyl | ||||